Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
989
datasets available to search
ShareScore release 0.9.0
Dataset results
989 results for “myelodysplastic syndrome”
Study of the Safety and Efficacy of CC-5013 Treatment For Patients With Myelodysplastic Syndrome
ClinicalTrials.gov study NCT00044382. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy and Safety of 5-day Dosing of ON 01910.Na in Intermediate-1,-2, or High Risk Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT00867061. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT01515527. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Azacitidine Combined to Epoetin Beta in International Prognostic Scoring System (IPSS) Low-risk and Intermediate-1 Myelodysplastic Syndrome (MDS) Patients, Resistant to Erythropoetin-stimulating Agent
ClinicalTrials.gov study NCT01015352. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia
ClinicalTrials.gov study NCT00002926. IPD Sharing: Not stated. Countries: 9. Publications: 1.
Cladribine, Idarubicin, Cytarabine, and Venetoclax in Treating Patients With Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome, or Blastic Phase Chronic Myeloid Leukemia
ClinicalTrials.gov study NCT02115295. IPD Sharing: Not stated. Countries: 1. Publications: 4.
CPX-351 in Higher Risk Myelodysplastic Syndromes
ClinicalTrials.gov study NCT04273802. IPD Sharing: NO. Countries: 1. Publications: 1.
Efficacy and Safety Study of CC-5013 Monotherapy in Subjects With Myelodysplastic Syndromes
ClinicalTrials.gov study NCT00064974. IPD Sharing: Not stated. Countries: 15. Publications: 1.
CD34+ Enriched Transplants to Treat Myelodysplastic Syndrome
ClinicalTrials.gov study NCT05617625. IPD Sharing: NO. Countries: 1. Publications: 7.
Vosaroxin and Azacitidine in Treating Patients With Myelodysplastic Syndromes
ClinicalTrials.gov study NCT01913951. IPD Sharing: NO. Countries: 1. Publications: 1.
Monoclonal Antibody Plus Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes
ClinicalTrials.gov study NCT00028899. IPD Sharing: Not stated. Countries: 3. Publications: 1.
Study for Epidemiology and Characterization of Myelodysplastic Syndromes (MDS) and Juvenile Myelomonocytic Leucemia (JMML) in Childhood
ClinicalTrials.gov study NCT00662090. IPD Sharing: Not stated. Countries: 1. Publications: 7.
Metoclopramide to Treat Anemia in Patients With Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT00120653. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Sorafenib and Low Dose Cytarabine in Older Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
ClinicalTrials.gov study NCT00516828. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of H3B-8800 (RVT-2001) in Participants With Lower Risk Myelodysplastic Syndromes
ClinicalTrials.gov study NCT02841540. IPD Sharing: Not stated. Countries: 7. Publications: 1.
Safety, Pharmacokinetics, and Pharmacodynamics of Oral Azacitidine in Subjects With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia and Acute Myelogenous Leukemia
ClinicalTrials.gov study NCT00528983. IPD Sharing: Not stated. Countries: 1. Publications: 3.
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
ClinicalTrials.gov study NCT03113643. IPD Sharing: NO. Countries: 1. Publications: 2.
Decitabine and Arsenic Trioxide for Myelodysplastic Syndrome(MDS)
ClinicalTrials.gov study NCT03377725. IPD Sharing: Not stated. Countries: 1. Publications: 6.
The Efficacy of Azacitidine +/- Lenalidomide in High-risk Myelodysplastic Syndrome (MDS)and Acute Myeloid Leukemia (AML) With Del(5q).
ClinicalTrials.gov study NCT01556477. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Amifostine in Treating Young Patients With Newly Diagnosed De Novo Myelodysplastic Syndromes
ClinicalTrials.gov study NCT00098683. IPD Sharing: Not stated. Countries: 4. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.